Poly(ADP-ribose)polymerase-1 (PARP-1) is thought to be required for apoptosis-inducing factor (AIF) release from mitochondria in caspase-independent apoptosis. The mechanism by which AIF is released through PARP-1 remains unclear. Here, we provide evidence that PARP-1-independent AIF release and cell death are induced by a trienoic fatty acid, ␣-eleostearic acid (␣-ESA). ␣-ESA induced the caspase-independent and AIF-initiated apoptotic death of neuronal cell lines, independently of PARP-1 activation. The cell death was inhibited by the MEK inhibitor U0126 and by knockdown of MEK using small interfering RNA. However, inhibitors for JNK, p38 inhibitors, calpain, phospholipase A 2 , and phosphatidylinositol 3-kinase, did not block cell death. AIF was translocated to the nucleus after the induction of apoptosis by ␣-ESA in differentiated PC12 cells without activating caspase-3 and PARP-1. The ␣-ESA-mediated cell death was not inhibited by PARP inhibitor 3,4-dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinoline and by knockdown of PARP-1 using small interfering RNA. Unlike N-methyl-N-nitro-N-nitrosoguanidine treatment, histonephosphorylated histone 2AX was not phosphorylated by ␣-ESA, which suggests no DNA damage. Overexpression of Bcl-2 did not inhibit the cell death. ␣-ESA caused a small quantity of superoxide production in the mitochondria, resulting in the reduction of mitochondrial membrane potential, both of which were blocked by a trace amount of ␣-tocopherol localized in the mitochondria. Our results demonstrate that ␣-ESA induces PARP-1-independent AIF release and cell death without activating Bax, cytochrome c, and caspase-3. MEK is also a key molecule, although the link between ERK, AIF release, and cell death remains unknown. Finding molecules that regulate AIF release may be an important therapeutic target for the treatment of neuronal injury.Apoptosis is a mode of programmed cell death that is used by multicellular organisms to remove surplus and unwanted cells in the immune and nervous systems (1-5). Apoptosis is characterized by cell detachment, cell shrinkage, chromatin condensation, DNA degradation, and plasma membrane blebbing (5-7). The surplus cells are removed by caspases, which are key effector molecules of apoptotic cell death. Apoptosis is activated through two main pathways as follows: the extrinsic pathway, which originates from the activation of cell-surface death receptors, such as Fas and tumor necrosis factor-receptor 1, and results in the activation of caspase-8; and the intrinsic pathway, which originates from the mitochondrial release of cytochrome c and results in the activation of caspase-9 through the Cyt-c 2 /apoptotic protease-activating factor-1/procaspase-9 heptamer (5, 8, 9). Most apoptotic stimuli use a mitochondriondependent process such as membrane potential shutdown and outer membrane permeabilization controlled by Bax and Bak, which are pro-apoptotic members of the Bcl-2 family (6 -9). This results in the release of the pro-apoptotic protein Cyt-c, which triggers caspa...